|
 | Up a level |
Sokhela, Simiso, Venter, Willem D.F., Bosch, Bronwyn, Woods, Joana, McCann, Kaitlyn, Akpomiemie, Godspower, Chandiwana, Nomathemba, Mashabane, Nkuli, Tembo, Angela, Simmons, Bryony 
ORCID: 0000-0002-3207-9935, Lalla-Edward, Samanta, Siedner, Mark J., Sinxadi, Phumla, Hermans, Lucas, Fairlie, Lee, Vos, Alinda, Abrams, Elaine, Manne-Goehler, Jennifer M., Moorhouse, Michelle, Clayden, Polly, Norris, Shane, Qavi, Ambar, Chersich, Matthew, Masenya, Masebole, Arulappan, Natasha and Hill, Andrew
(2024)
Final 192-week efficacy and safety results of the ADVANCE trial, comparing 3 first-line antiretroviral regimens.
Open Forum Infectious Diseases, 11 (3).
ISSN 2328-8957
Tovar Sanchez, Tamara, Mpoudi-Etame, Mireille, Kouanfack, Charles, Delaporte, Eric, Calmy, Alexandra, Venter, Francois, Sokhela, Simiso, Bosch, Bronwyn, Akpomiemie, Godspower, Tembo, Angela, Pepperrell, Toby, Simmons, Bryony ORCID: 0000-0002-3207-9935, Casas, Carmen Perez, McCann, Kaitlyn, Mirchandani, Manya and Hill, Andrew
(2023)
Risks of metabolic syndrome in the ADVANCE and NAMSAL trials.
Frontiers in Reproductive Health, 5.
ISSN 2673-3153
Zhao, Ying, Griesel, Rulan, Omar, Zaayid, Simmons, Bryony ORCID: 0000-0002-3207-9935, Hill, Andrew, van Zyl, Gert, Keene, Claire, Maartens, Gary and Meintjes, Graeme
(2023)
Initial supplementary dose of Dolutegravir in second-line antiretroviral therapy: a noncomparative, double-blind, randomized placebo-controlled trial.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 76 (10).
pp. 1832-1840.
ISSN 1058-4838
Sokhela, Simiso, Bosch, Bronwyn, Hill, Andrew, Simmons, Bryony ORCID: 0000-0002-3207-9935, Woods, Joana, Johnstone, Hilary, Akpomiemie, Godspower, Ellis, Leah, Owen, Andrew, Casas, Carmen Perez and Venter, Willem Daniel Francois
(2022)
Randomized clinical trial of nitazoxanide or sofosbuvir/daclatasvir for the prevention of SARS-CoV-2 infection.
The Journal of Antimicrobial Chemotherapy, 77 (10).
2706 - 2712.
ISSN 1460-2091
